Editorial overview: Antiviral strategies: Antiviral drug design: creating new ideas against old and new bugs.
作者信息
Naesens Lieve, Zoulim Fabien
出版信息
Curr Opin Virol. 2017 Jun;24:v-vii. doi: 10.1016/j.coviro.2017.07.007.
Abstract
摘要
相似文献
1
Editorial overview: Antiviral strategies: Antiviral drug design: creating new ideas against old and new bugs.编辑概述：抗病毒策略：抗病毒药物设计：针对新老病毒创造新思路。
Curr Opin Virol. 2017 Jun;24:v-vii. doi: 10.1016/j.coviro.2017.07.007.
2
Editorial overview: antivirals and resistance: advances and challenges ahead.社论综述：抗病毒药物与耐药性：未来的进展与挑战
Curr Opin Virol. 2014 Oct;8:iv-vii. doi: 10.1016/j.coviro.2014.08.002. Epub 2014 Aug 22.
3
Editorial overview: Engineering for viral resistance.编辑概述：抗病毒工程
Curr Opin Virol. 2015 Oct;14:v-vii. doi: 10.1016/j.coviro.2015.08.009. Epub 2015 Aug 28.
4
Human viral diseases: what is next for antiviral drug discovery?人类病毒性疾病：抗病毒药物研发的下一步是什么？
Curr Opin Virol. 2012 Oct;2(5):572-9. doi: 10.1016/j.coviro.2012.07.004. Epub 2012 Jul 28.
5
The program of antiviral agents inhibits virus infection.抗病毒药物程序可抑制病毒感染。
Arch Microbiol. 2018 Aug;200(6):841-846. doi: 10.1007/s00203-018-1525-z. Epub 2018 May 30.
6
Therapeutic Potential of Spirooxindoles as Antiviral Agents.螺环氧化吲哚作为抗病毒药物的治疗潜力
ACS Infect Dis. 2016 Jun 10;2(6):382-92. doi: 10.1021/acsinfecdis.6b00041. Epub 2016 May 5.
7
Antiviral strategies. Preface.
Handb Exp Pharmacol. 2009(189):v-vi.
8
What is the antiviral potential of pyrrole-imidazole polyamides?吡咯-咪唑聚酰胺的抗病毒潜力如何？
Future Med Chem. 2015;7(15):1953-5. doi: 10.4155/fmc.15.120. Epub 2015 Oct 23.
9
Antiviral Strategies Based on Lethal Mutagenesis and Error Threshold.基于致死性诱变和错误阈值的抗病毒策略。
Curr Top Microbiol Immunol. 2016;392:323-39. doi: 10.1007/82_2015_459.
10
Broad-Spectrum Antivirals and Antiviral Drug Combinations.广谱抗病毒药物和抗病毒药物组合。
Viruses. 2022 Feb 1;14(2):301. doi: 10.3390/v14020301.
本文引用的文献
1
Changes in mortality rates and causes of death in a population-based cohort of persons living with and without HIV from 1996 to 2012.1996年至2012年期间，一个以人群为基础的队列中，感染和未感染艾滋病毒人群的死亡率及死亡原因变化。
BMC Infect Dis. 2017 Feb 27;17(1):174. doi: 10.1186/s12879-017-2254-7.
2
New Vaccines against Epidemic Infectious Diseases.针对流行性传染病的新型疫苗
N Engl J Med. 2017 Feb 16;376(7):610-613. doi: 10.1056/NEJMp1613577. Epub 2017 Jan 18.
3
Zika Virus Methyltransferase: Structure and Functions for Drug Design Perspectives.寨卡病毒甲基转移酶：药物设计视角下的结构与功能
J Virol. 2017 Feb 14;91(5). doi: 10.1128/JVI.02202-16. Print 2017 Mar 1.
4
International AIDS Society global scientific strategy: towards an HIV cure 2016.国际艾滋病学会全球科学战略：迈向2016年治愈艾滋病
Nat Med. 2016 Aug;22(8):839-50. doi: 10.1038/nm.4108. Epub 2016 Jul 11.
5
Safety and Efficacy of Nucleic Acid Polymers in Monotherapy and Combined with Immunotherapy in Treatment-Naive Bangladeshi Patients with HBeAg+ Chronic Hepatitis B Infection.核酸聚合物单药治疗及联合免疫治疗初治的HBeAg阳性慢性乙型肝炎感染孟加拉患者的安全性和有效性
PLoS One. 2016 Jun 3;11(6):e0156667. doi: 10.1371/journal.pone.0156667. eCollection 2016.
6
First-in-human application of the novel hepatitis B and hepatitis D virus entry inhibitor myrcludex B.新型乙型肝炎和丁型肝炎病毒进入抑制剂 myrcludex B 的人体首用。
J Hepatol. 2016 Sep;65(3):483-9. doi: 10.1016/j.jhep.2016.04.013. Epub 2016 Apr 27.
7
Treatment of chronic hepatitis D with the entry inhibitor myrcludex B: First results of a phase Ib/IIa study.用进入抑制剂米鲁达宾治疗慢性丁型肝炎：Ib/IIa 期研究的初步结果。
J Hepatol. 2016 Sep;65(3):490-8. doi: 10.1016/j.jhep.2016.04.016. Epub 2016 Apr 27.
8
New antiviral targets for innovative treatment concepts for hepatitis B virus and hepatitis delta virus.新型抗病毒靶点为乙型肝炎病毒和丁型肝炎病毒的创新治疗概念提供了可能。
J Hepatol. 2016 Apr;64(1 Suppl):S117-S131. doi: 10.1016/j.jhep.2016.02.016.
9
Global strategies are required to cure and eliminate HBV infection.需要采取全球策略来治愈和消除乙肝病毒感染。
Nat Rev Gastroenterol Hepatol. 2016 Apr;13(4):239-48. doi: 10.1038/nrgastro.2016.7. Epub 2016 Feb 24.
10
Hepatitis C virus treatment in the real world: optimising treatment and access to therapies.现实世界中的丙型肝炎病毒治疗：优化治疗与治疗可及性
Gut. 2015 Nov;64(11):1824-33. doi: 10.1136/gutjnl-2015-310421.
Zotero 插件